HomeCAPS • NASDAQ
add
Capstone Therapeutics Corp
Previous close
$1.78
Day range
$2.16 - $3.29
Year range
$1.59 - $4.18
Market cap
12.72M USD
Avg Volume
58.43K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.90M | -15.60% |
Operating expense | 2.75M | 11.82% |
Net income | -1.73M | -55.26% |
Net profit margin | -21.88 | -84.02% |
Earnings per share | — | — |
EBITDA | -1.31M | -119.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.74M | — |
Total assets | 52.21M | — |
Total liabilities | 25.24M | — |
Total equity | 26.97M | — |
Shares outstanding | 5.19M | — |
Price to book | 0.34 | — |
Return on assets | -7.18% | — |
Return on capital | -7.94% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.73M | -55.26% |
Cash from operations | -2.29M | -84.06% |
Cash from investing | — | — |
Cash from financing | 4.02M | 204.24% |
Net change in cash | 1.73M | 8,352.38% |
Free cash flow | -1.71M | — |
About
Founded
1987
Headquarters
Website
Employees
36
